Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerCarcinoma, Ductal, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast disorder, breast ductal adenocarcinoma, breast neoplasm, carcinoma, epithelial neoplasm, neoplasm, skin disorderRecruitingNot applicable2026-09-23NCT07214532

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Natera, Inc.45

49 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Allegheny (AHN)PittsburghUnited States1
Atrium Levine Cancer InstituteCharlotteUnited States1
Baptist MD AndersonJacksonvilleUnited States3
Cancer & Hematology CentersGrand RapidsUnited States1
Cancer and Blood Research CenterLos AlamitosUnited States2
Cleveland ClinicClevelandUnited States558
Cooper HealthCamdenUnited States6
Fred Hutch Cancer CenterSeattleUnited States12
Hartford Healthcare InstituteHartfordUnited States1
Honor Health Research InstituteScottsdaleUnited States17
Houston Methodist HospitalHoustonUnited States260
Indiana UniversityIndianapolisUnited States160
InovaFairfaxUnited States1
Intermountain HealthGrand JunctionUnited States1
Jupiter Medical CancerJupiterUnited States1
Kaiser Permanente NorCalVallejoUnited States1
Karmanos Cancer Center - Wayne State UniversityDetroitUnited States1
Loma Linda UniversityLoma LindaUnited States19
Marin Cancer CareGreenbraeUnited States12
Massachusetts General HospitalBostonUnited States1015
Mayo ClinicRochesterUnited States664
Mayo Clinic ArizonaPhoenixUnited States55
Mayo Clinic FloridaJacksonvilleUnited States105
Mercy Health - Pratt Cancer CenterSt LouisUnited States1
Mercy Health - Sindelar Cancer CenterSt LouisUnited States1